Aadi Bioscience Company Top Insiders
AADI Stock | USD 2.98 0.15 4.79% |
Aadi Bioscience's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Aadi Bioscience suggests that almost all insiders are panicking. Aadi Bioscience employs about 53 people. The company is managed by 9 executives with a total tenure of roughly 124 years, averaging almost 13.0 years of service per executive, having 5.89 employees per reported executive.
Aadi Bioscience's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-10-03 | David James Lennon | Disposed 9689 @ 1.94 | View | ||
2024-09-03 | Neil Desai | Disposed 40000 @ 1.71 | View | ||
2024-08-05 | Neil Desai | Disposed 5652 @ 1.34 | View | ||
2024-08-01 | Neil Desai | Disposed 15415 @ 1.5 | View | ||
2024-07-01 | Neil Desai | Disposed 31348 @ 1.45 | View | ||
2024-05-01 | Neil Desai | Disposed 40000 @ 1.93 | View | ||
2024-04-01 | Neil Desai | Disposed 17772 @ 2.31 | View | ||
2024-03-04 | Neil Desai | Disposed 14964 @ 2.1 | View | ||
2024-03-01 | Neil Desai | Disposed 27036 @ 1.97 | View | ||
2024-02-01 | Neil Desai | Disposed 42000 @ 1.74 | View |
Monitoring Aadi Bioscience's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Aadi |
Aadi Bioscience's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Aadi Bioscience's future performance. Based on our forecasts, it is anticipated that Aadi will maintain a workforce of under 50 employees by February 2025.Aadi Bioscience Management Team Effectiveness
The company has return on total asset (ROA) of (0.3527) % which means that it has lost $0.3527 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6595) %, meaning that it created substantial loss on money invested by shareholders. Aadi Bioscience's management efficiency ratios could be used to measure how well Aadi Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.47. The current Return On Capital Employed is estimated to decrease to -0.64. As of now, Aadi Bioscience's Other Current Assets are increasing as compared to previous years. The Aadi Bioscience's current Non Current Assets Total is estimated to increase to about 9.5 M, while Intangible Assets are projected to decrease to under 3 M.The Aadi Bioscience's current Common Stock Shares Outstanding is estimated to increase to about 32.5 M, while Net Loss is projected to decrease to (57.2 M).
Aadi Bioscience Workforce Comparison
Aadi Bioscience is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 3,891. Aadi Bioscience claims roughly 53.0 in number of employees contributing just under 2% to equities under Health Care industry.
Aadi Bioscience Profit Margins
The company has Profit Margin (PM) of (2.46) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.49) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.49.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.97 | 1.02 |
|
|
Aadi Bioscience Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aadi Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aadi Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Aadi Bioscience insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 0.5 | 1 | 2 | 32,558 | 42,247 |
2024-06-01 | 0.7 | 7 | 10 | 320,824 | 377,500 |
2024-03-01 | 2.25 | 9 | 4 | 612,844 | 126,000 |
2023-12-01 | 0.25 | 2 | 8 | 522,558 | 126,000 |
2023-06-01 | 0.5833 | 7 | 12 | 269,530 | 126,000 |
2021-12-01 | 1.0 | 1 | 1 | 185,000 | 200,000 |
2021-09-01 | 3.0 | 12 | 4 | 5,719,785 | 63,440 |
2020-12-01 | 0.5 | 1 | 2 | 21,400 | 42,800 |
2019-12-01 | 0.25 | 1 | 4 | 44,300 | 263,300 |
2019-06-01 | 0.8125 | 13 | 16 | 2,138,000 | 1,370,000 |
2019-03-01 | 3.0 | 12 | 4 | 1,124,146 | 380,446 |
2018-09-01 | 0.5 | 1 | 2 | 268,987 | 1,608,826 |
2018-06-01 | 5.0 | 15 | 3 | 4,338,382 | 150,228 |
2017-03-01 | 1.1429 | 8 | 7 | 3,981,930 | 398,421 |
Aadi Bioscience Notable Stakeholders
An Aadi Bioscience stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Aadi Bioscience often face trade-offs trying to please all of them. Aadi Bioscience's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Aadi Bioscience's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David Lennon | CEO President | Profile | |
Scott CPA | Treasurer, CFO | Profile | |
Neil Desai | President, Founder | Profile | |
Raymond Steitz | Senior Officer | Profile | |
Bryan Ball | Chief Operations | Profile | |
Marcy Graham | SVP Communications | Profile | |
Stephen JD | Senior Counsel | Profile | |
Brendan MBA | Chief Officer | Profile | |
MD FACP | Chief Officer | Profile |
About Aadi Bioscience Management Performance
The success or failure of an entity such as Aadi Bioscience often depends on how effective the management is. Aadi Bioscience management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aadi management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aadi management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.45) | (0.47) | |
Return On Capital Employed | (0.61) | (0.64) | |
Return On Assets | (0.45) | (0.47) | |
Return On Equity | (0.56) | (0.59) |
Aadi Bioscience Workforce Analysis
Traditionally, organizations such as Aadi Bioscience use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Aadi Bioscience within its industry.Aadi Bioscience Manpower Efficiency
Return on Aadi Bioscience Manpower
Revenue Per Employee | 459.5K | |
Revenue Per Executive | 2.7M | |
Net Loss Per Employee | 1.2M | |
Net Loss Per Executive | 7.3M | |
Working Capital Per Employee | 1.9M | |
Working Capital Per Executive | 10.9M |
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |